S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RA Capital Management/Q1 2022

RA Capital Management

Period: Q1 2022 Β· Filed: 2022-05-16
View on SEC EDGAR β†—
AUM
$4.58B
Total portfolio value
Positions
96
Reported securities
Top Holding
ASND
19.4% $888.2M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2022-05-16) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ASNDASCENDIS PHARMA A/S$888.2M19.38%$117.36$274.50+133.9%
19.4%
BIIBBIOGEN INC$153.1M3.34%$210.60$216.12+2.6%
3.3%
AVTEAEROVATE THERAPEUTICS INC$151.5M3.31%β€”β€”
3.3%
CTKBCYTEK BIOSCIENCES INC$144.3M3.15%$10.78$4.59-57.4%
3.1%
ITOSITEOS THERAPEUTICS INC$142.2M3.10%β€”β€”
3.1%
TVTXTRAVERE THERAPEUTICS INC$126.9M2.77%$25.77$56.92+120.9%
2.8%
JANXJANUX THERAPEUTICS INC$124.3M2.71%$14.34$15.54+8.4%
2.7%
PCVXVAXCYTE INC$110.6M2.41%$24.15$58.39+141.8%
2.4%
CLYMELIEM THERAPEUTICS INC$110.3M2.41%$8.39$12.90+53.8%
2.4%
IMGNIMMUNOGEN INC$103.5M2.26%β€”β€”
2.3%
DICEDICE THERAPEUTICS INC$99.7M2.17%β€”β€”
2.2%
GHRSGH RESEARCH PLC$88.3M1.93%$18.29$27.01+47.7%
1.9%
FMTXFORMA THERAPEUTICS HLDGS INC$83.8M1.83%β€”β€”
1.8%
TYRATYRA BIOSCIENCES INC$77.4M1.69%$10.70$30.62+186.2%
1.7%
PNTPOINT BIOPHARMA GLOBAL INC$71.8M1.57%β€”β€”
1.6%
CLDXCELLDEX THERAPEUTICS INC NEW$70.7M1.54%$34.06$38.37+12.7%
1.5%
BLUBELLUS HEALTH INC NEW$70.4M1.54%β€”β€”
1.5%
ENTAENANTA PHARMACEUTICALS INC$68.6M1.50%$71.18$15.11-78.8%
1.5%
VORXXXXVOR BIOPHARMA INC$67.2M1.47%β€”β€”
1.5%
NKTXNKARTA INC$63.8M1.39%$11.38$3.22-71.7%
1.4%
MRTXMIRATI THERAPEUTICS INC$60.4M1.32%β€”β€”
1.3%
DAWNDAY ONE BIOPHARMACEUTICALS I$60.1M1.31%β€”β€”
1.3%
RYTMRHYTHM PHARMACEUTICALS INC$56.1M1.22%$11.52$114.17+891.1%
1.2%
ANTXAN2 THERAPEUTICS INC$55.3M1.21%$15.07$4.42-70.7%
1.2%
RLMDRELMADA THERAPEUTICS INC$54.0M1.18%$26.99$6.28-76.7%
1.2%
MGNXMACROGENICS INC$53.8M1.17%$8.81$4.71-46.5%
1.2%
NTRANATERA INC$53.3M1.16%$40.68$279.32+586.6%
1.2%
TILINSTIL BIO INC$52.4M1.14%$215.00$7.73-96.4%
1.1%
NVAXNOVAVAX INC$51.0M1.11%$73.65$9.74-86.8%
1.1%
KNTEKINNATE BIOPHARMA INC$48.0M1.05%β€”β€”
1.1%

Quarter-on-Quarter Activity

Q1 2022 vs. Q4 2021

New Positions (8)

TickerIssuerNotionalSince Filing
BIIBBIOGEN INC$153.1M+2.6%
ENTAENANTA PHARMACEUTICALS INC$68.6M-78.8%
ANTXAN2 THERAPEUTICS INC$55.3M-70.7%
NTRANATERA INC$53.3M+586.6%
VERAVERA THERAPEUTICS INC$46.2M
GHGUARDANT HEALTH INC$31.6M
ACRSACLARIS THERAPEUTICS INC$31.3M
CCXICHEMOCENTRYX INC$29.0M

Exited Positions (8)

TickerIssuerNotional
PHATPHATHOM PHARMACEUTICALS INC$61.3M
ZGNXZOGENIX INC$54.2M
CCCCC4 THERAPEUTICS INC$44.4M
TGTXTG THERAPEUTICS INC$42.0M
IVVDADAGIO THERAPEUTICS INC$36.3M
NAUTNAUTILUS$12.6M
BOLTBOLT BIOTHERAPEUTICS INC$11.7M
SPRYSILVERBACK THERAPEUTICS INC$11.6M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
RNAMAVIDITY BIOSCIENCES INC$30.0M+411.6%
PRDSPARDES BIOSCIENCES INC$-6.6M+97.5%
MRTXMIRATI THERAPEUTICS INC$4.5M+92.7%
GHRSGH RESEARCH PLC$21.9M+69.8%+47.7%
CTKBCYTEK BIOSCIENCES INC$-12.5M+39.3%-57.4%
DAWNDAY ONE BIOPHARMACEUTICALS I$-23.6M+22.0%
KNTEKINNATE BIOPHARMA INC$-15.7M+18.7%
CLDXCELLDEX THERAPEUTICS INC NEW$0.9M+15.0%+12.7%

Trimmed (7)

TickerIssuerNotionalShares Ξ”Since Filing
OLMAOLEMA PHARMACEUTICALS INC$-18.0M-76.5%
CMPXCOMPASS THERAPEUTICS INC$-5.1M-71.2%
NVAXNOVAVAX INC$-249.1M-67.0%-86.8%
TCRXTSCAN THERAPEUTICS INC$-2.8M-18.6%
TVTXTRAVERE THERAPEUTICS INC$-47.4M-12.3%+120.9%
LRMRLARIMAR THERAPEUTICS INC$-9.2M-4.0%
SCPHSCPHARMACEUTICALS INC$1.6M-1.2%
← Back to Hedge Funds